Todd C Brady
CIK 1579179 · President and CEO · last filed 2026-06-05
Todd C Brady is a President and CEO who has filed 63 SEC Form 4 insider transactions across 7 companies since 2013. The most recent filing shows the insider bought $418.4K of ALDX on Jun 5, 2026. Across all open-market trades the lifetime net is +$612.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.03M
7
63
$612.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALDX | President and CEO | 1,721,298 | $1.76 | $3.03M | $589.8K | 25 | 2026-06-05 |
| Evoke Pharma Inc (EVOK) Delisted | Director | 0 | $11.00 | $0 | $0 | 9 | 2025-12-17 |
| F-star Therapeutics, Inc. (FSTX) Delisted | Director | 0 | $7.12 | $0 | $0 | 3 | 2023-03-09 |
| F-star Therapeutics, Inc. (SBPH) Delisted | Director | 60,016 | — | — | $0 | 17 | 2020-11-23 |
| Evoke Pharma Inc (OMED) Delisted | Director | 4,000 | — | — | $22.8K | 6 | 2018-04-27 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | 153,288 | — | — | $0 | 2 | 2017-10-30 |
| Outlook Therapeutics, Inc. (ONSI.U) Delisted | Director | 124,303 | — | — | $0 | 1 | 2016-05-18 |
Recent Filings
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | ALDX | Buy (P) | +250,000 | $418.4K | EDGAR |
| 2025-12-17 | Evoke Pharma Inc (EVOK) Delisted | Mixed | −27 | $0 | EDGAR |
| 2025-05-22 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-06 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-12 | ALDX | Mixed | −183,238 | -$580.8K | EDGAR |
| 2023-09-11 | ALDX | Mixed | +199,251 | -$382.2K | EDGAR |
| 2023-05-11 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-09 | F-star Therapeutics, Inc. (FSTX) Delisted | Mixed | −15,004 | -$106.8K | EDGAR |